0SUN3JZ
Supplement Metatarsal-Phalangeal Joint, Left to No Qualifier with Synthetic Substitute, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | S Lower Joints |
| Operation | U Supplement |
| Body Part | N Metatarsal-Phalangeal Joint, Left |
| Approach | 3 Percutaneous |
| Device | J Synthetic Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures add biological or synthetic material to reinforce or augment a lower joint that is still structurally present but needs additional support. Ligament reconstruction, such as an ACL or PCL graft in the knee, is the classic example, along with labral augmentation in the hip or cartilage grafting. Unlike replacement, the native joint stays in place; the surgery strengthens a weakened or torn portion of it.
Grafts can come from the patient's own tissue, a donor, or synthetic material, and the choice often depends on age, activity level, and the structure being reinforced. These procedures are common after athletic injuries, aiming to restore stability so the joint can withstand normal or athletic loads again.
Anatomy & Axis Detail
Metatarsal-Phalangeal Joint, Left
On the left foot, the metatarsal-phalangeal joint, particularly the first MTP joint, can be supplemented when degenerative or inflammatory changes have thinned its cartilage or stretched its plantar plate without collapsing the joint entirely. Surgeons introduce a cartilage substitute or graft to the joint surface or supporting plate, aiming to preserve the toe's ability to dorsiflex during the propulsive phase of walking, which is essential for a normal push-off. This option is often favored over arthroplasty in younger or more active patients who want to avoid the motion restrictions that come with fusion. Precise documentation of the specific toe joint and graft type is necessary, since lesser toe MTP joints are coded distinctly from the great toe.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Device: Synthetic Substitute
Synthetic Substitute designates a device made from manufactured, non-biologic material, such as mesh or prosthetic components, used to replace or augment a body part. It is distinguished from the two tissue substitute categories by its artificial composition, which carries different considerations for integration and long-term durability than biologic grafts.
Coding & Documentation
Coders assign Supplement when documentation shows material was added to reinforce an existing body part rather than substitute for it, which requires confirming the native structure was not removed. Graft type, whether autograft, allograft, or synthetic, factors into the device value. A recurring mistake is coding a ligament reconstruction as Repair when a formal graft was placed, or conversely coding Supplement when the graft actually replaced a joint surface rather than reinforcing intact tissue.
